MENU
STAA
AS OF
Feb 4, 01:31 PM (EDT)
Price
$17.71
Change
-$0.43 (-2.37%)
Capitalization
895.99M
21 days until earnings call
Intraday BUY SELL Signals
+Compare
STAA
Stock ticker: NASDAQ
AS OF
Feb 4, 01:31 PM (EDT)
Price
$17.71
Change
-$0.43 (-2.37%)
Capitalization
895.99M

STAA STAAR Surgical Company Forecast, Technical & Fundamental Analysis

Staar Surgical Co is a manufacturer of lenses... Show more

STAA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for STAA with price predictions
Feb 03, 2026

STAA's RSI Oscillator is sitting in oversold zone for 8 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

STAA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STAA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for STAA entered a downward trend on February 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.533) is normal, around the industry mean (11.448). P/E Ratio (49.727) is within average values for comparable stocks, (149.436). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.437). STAA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (3.891) is also within normal values, averaging (111.001).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. STAA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STAA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
STAA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

STAA is expected to report earnings to fall 14.83% to 15 cents per share on February 25

STAAR Surgical Company STAA Stock Earnings Reports
Q4'25
Est.
$0.15
Q3'25
Est.
$0.18
Q2'25
Beat
by $0.22
Q1'25
Missed
by $0.52
Q4'24
Missed
by $0.66
The last earnings report on November 05 showed earnings per share of 18 cents, meeting the estimate of 18 cents. With 140.36K shares outstanding, the current market capitalization sits at 895.99M.
A.I. Advisor
published General Information

General Information

a designer of implantable lenses for the eye and delivery systems used to deliver lenses into the eye

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
25651 Atlantic Ocean Drive
Phone
+1 626 303-7902
Employees
1115
Web
https://www.staar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIDHX33.160.17
+0.52%
MFS International New Discovery R3
MIAPX29.650.13
+0.44%
Matthews Asia Growth Instl
BSGRX16.13-0.03
-0.19%
BlackRock Advantage Small Cap Gr R
AICGX40.42-0.11
-0.27%
American Century Discplnd Cor Val R5
GSPFX19.26-0.18
-0.93%
Gotham Enhanced S&P 500 Index Instl

STAA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STAA has been loosely correlated with XRAY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then XRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
-4.80%
XRAY - STAA
53%
Loosely correlated
-2.09%
WST - STAA
44%
Loosely correlated
+2.76%
OFIX - STAA
38%
Loosely correlated
+1.66%
CSTL - STAA
38%
Loosely correlated
+0.20%
IQV - STAA
37%
Loosely correlated
+0.47%
More

Groups containing STAA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
-4.80%
Pharmaceuticals: Other
industry (107 stocks)
16%
Poorly correlated
-0.87%
Pharmaceuticals
industry (380 stocks)
15%
Poorly correlated
+27.23%